期刊文献+

静脉用环丙沙星在开放性眼外伤眼内渗透性研究

Clinical study on the ocular penetration of intravenous ciprofloxacin in open globe injury of human eyes
原文传递
导出
摘要 目的探讨在开放性眼外伤患者单剂量静脉滴注环丙沙星的眼内渗透性。方法选择16例非化脓开放性眼外伤和12例住院白内障手术为正常对照的患者,单次静脉滴注环丙沙星注射液200mg后1h抽取少许房水和玻璃体,采用高效液相色谱法检测眼内环丙沙星浓度,双缩脲法检测房水蛋白含量。结果正常对照组的房水蛋白含量是(0.067±0.037)g/L,开放性眼外伤组是(6.482±2.981)g/L,开放性眼外伤组的房水蛋白含量明显高于正常对照组,P〈0.05。在对照组房水中环丙沙星浓度是(0.158±0.035)μg/ml,开放性眼外伤组房水中环丙沙星浓度是(0.175±0.142)μg/ml,开放性眼外伤组与对照组相比P〉0.05,浓度差异无统计学意义。开放性眼外伤组玻璃体中环丙沙星浓度(0.082±0.022)μg/ml,环丙沙星在眼内不能达到眼内炎常见致病菌的体外90%最小抑菌浓度((MIC90)。结论在开放性外伤眼的血房水屏障破坏,但环丙沙星眼内渗透性并没有增强,单剂量静脉滴注后不能在眼内达到有效的抑菌浓度,在围手术期用药不能达到预期的抗菌效果。 Objective To assess the ocular penetration of ciprofloxacin in open globe injury of human eyes after a single dose intravenous administration.Methods In this prospective study, 16 patients with non-purulent open globe injury were studied.The normal control group included 12 patients underwent cataract surgery.All the patients received continuously intravenous infusion of 200mg ciprofloxacin before surgery.The aqueous samples were obtained in both group and in open globe injury group vitreous humour samples were also obtained.Drug concentrations were measured using high-pressure liquid chromatography analysis and protein concentration of aqueous humor was measured by biuret conorimetric method simultaneously.Results 1.The protein concentration of aqueous humor in open globe injury group (6.482±2.981 g/l)were significantly higher than that of the control group (0.067±0.037g/1), (P〈0.05).2.The ciprofloxacin concentration of aqueous humor in open globe injury group and the control group were 0.175±0.142μg/ml and 0.158±0.035μml respectively.There were no significant difference between the two groups (P〉0.05).3.The vitreous concentration of ciprofloxacin in open globe injury group was 0.082±0.022μg/ml.The vitreous levels of ciprofloxacin in open globe injury group could not exceed the 90% minimum inhibitory concentration(MIC90 )of common ocular pathogens causing endophthalmitis.Conclusions In the open-globe injured eye the blood-ocular barrier was damaged, but the ocular penetration of ciprofloxacin didn't enhance.The levels of intraocular ciprofloxacin after a single dose of intravenous administration couldn' t reach effective therapeutic concentration.
出处 《中国实用眼科杂志》 CSCD 北大核心 2009年第7期736-738,共3页 Chinese Journal of Practical Ophthalmology
基金 广东省中医药管理局经费资助项目(1050065)
关键词 环丙沙星 静脉滴注 眼内渗透性 开放性眼外伤 Ciprofloxacin Continuously intravenous infusion Ocular penetration Open globe injury
  • 相关文献

参考文献12

  • 1惠延年.外伤性感染性眼内炎[A].李凤鸣 主编.眼科全书:第1版[C].北京:人民卫生出版社,1996.3266.
  • 2Essex RW,Yi Q,Charles PG,et al.Post-traumatic endophthalmitis.Oph-thalmology,2004,111(11):2015-22.
  • 3Cokingtin CD,Hyndiuk RA.Insights from experimental data on cip-rofloxacin in the treatment of bacterial keratitis and ocular infections.Am J Ophthalmol,1991,112(ciprofloxacin suppl):25S-28S
  • 4朱曼,王睿.第四代氟喹诺酮类抗菌药——加替沙星[J].中国临床药理学与治疗学,2001,6(4):377-381. 被引量:71
  • 5Alfaro D.V.,Hudson S.J.,Rafanan M.M.,et al.The effect of trauma on the ocular penetration of intravenous ciprofloxacin.Am J Ophthalmol,1996,122(5):678-683.
  • 6孟宪敏.房水蛋白的研究[J].国外医学:眼科学分册,1986,(5):293-295.
  • 7Behrens-Baumannde W,Martell J.Ciprofloxacin concentration in the rabbit aqueous humor and vitreous following intravenous and subcon-junctive administration.Infection,1988,16:54-57.
  • 8Cekic O,Batman C,Yasar U,Basci NE,et al.Subretinal fluid levels of topical,oral,and combined administered ciprofloxacin in humans.Br Ophthalmol,2000,84 (9):1061-1063.
  • 9Lesk M.R.,Ammann H.,Marcil G.,et al.The penetration of oral ciprofloxacin into the aqueous humor,vitreous,and subretinal fluid of humans.American Journal of Ophthalmology,1993,115 (5):623-628.
  • 10Celebi S,Ay S,Aykan U,et al.Penetration of oral and topical cipro-floxacin into human aqueous humor.Acta Ophthalmol Scand,1998,76(6):683-685.

二级参考文献21

  • 1赵树清,王金生.新型氟喹诺酮抗菌剂——AM—1155[J].中国医药情报,1996,2(4):249-252. 被引量:4
  • 2JLM. Oral and iv formulations of gatifoxacin cleared for US. market. Am J Health-Syst Pharm, 2000; 57:204
  • 3Hosaka M, Kinoshita S, Toyama A, et al. Antibacterial properties of AM-1155, a new 8-methoxy quinolone. J Antimicrob Chemther,1995; 36:293
  • 4Tomioka H, Saito H, Sato K. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin and ofloxacin. Antimicrob Agents Chemother, 1993;37:1259
  • 5Takei M, Fukuda H, Yasue T, et al. Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian typeⅡ topoisomerase. Antimicro Agents Chemother, 1998;42:2678
  • 6Wakabayshi E, Mitsuhashi S. In vitro antibacterial activitiy of AM-1155, a novel 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother, 1994;38:594
  • 7Fukuda H, Hori S, Hiramatsu K. Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone- resistants mutants and the norA transformant of staphylococcus aureus. Antimicrob Agents Chemother, 1998;42:1917
  • 8Deguchi T, Yasuda M, Nakano M, et al. Comparision of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC. Chemotherapy, 1997;43:239
  • 9Appelbaum PC. Quinolone activity against anaerobes. Drugs, 1999;58 (suppl 2):60
  • 10Ednie LM, Jacobs M, Appelaum PC. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms. Antimicrob Agents Chemother, 1998;42:2459

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部